Effect	NN
of	IN
pirfenidone	NN
on	IN
proliferation	NN
,	,
TGF-b-induced	JJ
myofibroblast	NN
differentiation	NN
and	CC
fibrogenic	JJ
activity	NN
of	IN
primary	JJ
human	JJ
lung	NN
fibroblasts	NNS
.	.

Pirfenidone	NNP
is	VBZ
an	DT
orally	RB
active	JJ
small	JJ
molecule	NN
that	WDT
has	VBZ
been	VBN
shown	VBN
to	TO
inhibit	VB
the	DT
progression	NN
of	IN
fibrosis	NN
in	IN
animal	NN
models	NNS
and	CC
in	IN
patients	NNS
with	IN
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
.	.

Although	IN
pirfenidone	NN
exhibits	VBZ
well	RB
documented	VBN
antifibrotic	JJ
and	CC
antiinflammatory	JJ
activities	NNS
,	,
in	FW
vitro	FW
and	CC
in	FW
vivo	FW
,	,
its	PRP$
molecular	JJ
targets	NNS
and	CC
mechanisms	NNS
of	IN
action	NN
have	VBP
not	RB
been	VBN
elucidated	VBN
.	.

In	IN
this	DT
study	NN
,	,
we	PRP
investigated	VBD
the	DT
effects	NNS
of	IN
pirfenidone	NN
on	IN
proliferation	NN
,	,
TGF-b-induced	JJ
differentiation	NN
and	CC
fibrogenic	JJ
activity	NN
of	IN
primary	JJ
human	JJ
lung	NN
fibroblasts	NNS
(	(
HLFs	NNS
)	)
.	.

Pirfenidone	NNP
reduced	VBD
fibroblast	NN
proliferation	NN
and	CC
attenuated	VBD
TGF-b-induced	JJ
a-smooth-muscle-actin	NN
(	(
SMA	NN
)	)
and	CC
pro-collagen	NN
(	(
Col	NN
)	)
-	:
I	PRP
mRNA	NN
and	CC
protein	NN
levels	NNS
.	.

Importantly	RB
,	,
pirfenidone	NN
inhibited	VBD
TGF-b-induced	JJ
phosphorylation	NN
of	IN
Smad3	NN
,	,
p38	NN
,	,
and	CC
Akt	NN
,	,
key	JJ
factors	NNS
in	IN
the	DT
TGF-b	NN
pathway	NN
.	.

Together	RB
,	,
these	DT
results	NNS
demonstrate	VBP
that	IN
pirfenidone	NN
modulates	VBZ
HLF	NN
proliferation	NN
and	CC
TGF-b-mediated	JJ
differentiation	NN
into	IN
myofibroblasts	NNS
by	IN
attenuating	VBG
key	JJ
TGF-b-induced	JJ
signaling	NN
pathways	NNS
.	.

